Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxter splashes out $325m on biomaterials firm Synovis

This article was originally published in Clinica

Executive Summary

Baxter International has boosted its regenerative and biosurgical offering by agreeing to acquire Synovis Life Technologies, which develops products for soft tissue repair during surgery. The deal is worth $28 per share, which equates to $325m of equity or around $260m after adjusting for net cash.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT098289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel